{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T14:23:17Z","timestamp":1783520597353,"version":"3.55.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biol Toxicol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Parkinson\u2019s disease (PD) is featured by progressive neurodegeneration linked to iron-dependent ferroptosis, yet the functions of m\n                      <jats:sup>6<\/jats:sup>\n                      A RNA-binding proteins and deubiquitinating enzymes in this process remain poorly understood. This work investigates the functional interplay between the m\n                      <jats:sup>6<\/jats:sup>\n                      A reader YTHDF2 and deubiquitinase CYLD in PD-associated ferroptosis and delineates their downstream molecular mechanisms.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      PD models were established using MPTP-treated C57BL\/6 mice and MPP\n                      <jats:sup>+<\/jats:sup>\n                      -exposed SH-SY5Y neuroblastoma cells. Behavioral assessments (open field, rotarod, and pole tests) and pain sensitivity assays (mechanical allodynia, thermal hyperalgesia) were performed. Molecular analyses included qRT-PCR, Western blot, RNA immunoprecipitation (RIP), co-immunoprecipitation (Co-IP), and ubiquitination assays. Ferroptosis markers (Fe\n                      <jats:sup>2+<\/jats:sup>\n                      , ROS, MDA, and GSH) and key regulators (ACSL4, GPX4, SLC7A11, and FTL) were quantified. Gain- and loss-of-function experiments for YTHDF2, CYLD, and NOX4 were conducted to validate regulatory relationships.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      MPTP\/MPP\n                      <jats:sup>+<\/jats:sup>\n                      treatment downregulated YTHDF2 and upregulated CYLD, exacerbating ferroptosis, as evidenced by mitochondrial damage, elevated Fe\n                      <jats:sup>2+<\/jats:sup>\n                      \/ROS\/MDA, reduced GSH, and altered level of ferroptosis-associated proteins (ACSL4 increased, GPX4\/SLC7A11\/FTL decreased). YTHDF2 overexpression suppressed ferroptosis, at least in part, by recognizing m6A-modified CYLD mRNA and promoting its degradation. Moreover, CYLD stabilized NOX4 by inhibiting its ubiquitination. Rescue experiments confirmed that CYLD depletion attenuated ferroptosis, an effect that was rescued by NOX4 overexpression. In MPTP-induced mice, YTHDF2 overexpression alleviated motor deficits (improved locomotion, rotarod performance), and reduced pain hypersensitivity, while mitigating ferroptosis markers and nigral mitochondrial pathology.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study uncovered the YTHDF2\/CYLD\/NOX4 axis as a novel ferroptosis regulator in PD, revealing a dual epitranscriptomic-posttranslational therapeutic target for neuroprotection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                    <jats:p>Inhibition of YTHDF2-mediated CYLD mRNA decay promotes neuronal ferroptosis and pain in PD via NOX4 deubiquitination.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10565-026-10204-0","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T13:25:22Z","timestamp":1780752322000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inhibition of YTHDF2-mediated CYLD mRNA degradation promotes neuronal ferroptosis and pain in Parkinson's disease through NOX4 deubiquitination"],"prefix":"10.1007","volume":"42","author":[{"given":"Fei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuwei","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanmei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongjiao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianguo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,6]]},"reference":[{"key":"10204_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102698","volume":"62","author":"N Boonpraman","year":"2023","unstructured":"Boonpraman N, et al. NOX4 as a critical effector mediating neuroinflammatory cytokines, myeloperoxidase and osteopontin, specifically in astrocytes in the hippocampus in Parkinson\u2019s disease. Redox Biol. 2023;62:102698.","journal-title":"Redox Biol."},{"key":"10204_CR2","doi-asserted-by":"publisher","first-page":"1235524","DOI":"10.3389\/fnins.2023.1235524","volume":"17","author":"J Cai","year":"2023","unstructured":"Cai J, et al. Sex, myelin, and clinical characteristics of Parkinson\u2019s disease. Front Neurosci. 2023;17:1235524.","journal-title":"Front Neurosci."},{"issue":"7","key":"10204_CR3","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.3390\/antiox12071369","volume":"12","author":"A Cardile","year":"2023","unstructured":"Cardile A, et al. Hyperforin enhances heme oxygenase-1 expression triggering lipid peroxidation in BRAF-mutated melanoma cells and hampers the expression of pro-metastatic markers. Antioxidants Basel. 2023;12(7):1369.","journal-title":"Antioxidants Basel."},{"issue":"11","key":"10204_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.787","volume":"5","author":"X Chen","year":"2024","unstructured":"Chen X, et al. RNA modification in normal hematopoiesis and hematologic malignancies. MedComm. 2024a;5(11):e787.","journal-title":"MedComm."},{"issue":"3","key":"10204_CR5","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1093\/jnen\/nlad102","volume":"83","author":"H Chen","year":"2024","unstructured":"Chen H, et al. YTHDF2-regulated matrilin-3 mitigates post-reperfusion hemorrhagic transformation in ischemic stroke via the PI3K\/AKT pathway. J Neuropathol Exp Neurol. 2024b;83(3):194\u2013204.","journal-title":"J Neuropathol Exp Neurol."},{"key":"10204_CR6","doi-asserted-by":"publisher","unstructured":"Chu J, et al. The role of cellular defense systems of ferroptosis in Parkinson\u2019s disease and Alzheimer\u2019s disease. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241814108.","DOI":"10.3390\/ijms241814108"},{"key":"10204_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.995747","volume":"13","author":"J Deng","year":"2022","unstructured":"Deng J, et al. m6A RNA methylation in brain injury and neurodegenerative disease. Front Neurol. 2022;13:995747.","journal-title":"Front Neurol."},{"issue":"1","key":"10204_CR8","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41419-025-07510-6","volume":"16","author":"R Deng","year":"2025","unstructured":"Deng R, et al. Inhibition of mitochondrial complex I induces mitochondrial ferroptosis by regulating CoQH2 levels in cancer. Cell Death Dis. 2025;16(1):254.","journal-title":"Cell Death Dis."},{"key":"10204_CR9","unstructured":"Diemert S. The role of p53 and CYLD in mitochondrial death pathways and mechanisms of neuronal necroptosis."},{"key":"10204_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-020-01735-3","volume":"39","author":"C Du","year":"2020","unstructured":"Du C, et al. Activation of the KDM5A\/miRNA-495\/YTHDF2\/m6A-MOB3B axis facilitates prostate cancer progression. J Exp Clin Cancer Res. 2020;39:1\u201314.","journal-title":"J Exp Clin Cancer Res."},{"issue":"5","key":"10204_CR11","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00401-022-02488-3","volume":"144","author":"Y Fu","year":"2022","unstructured":"Fu Y, et al. Adaptive structural changes in the motor cortex and white matter in Parkinson\u2019s disease. Acta Neuropathol. 2022;144(5):861\u201379.","journal-title":"Acta Neuropathol."},{"key":"10204_CR12","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.expneurol.2016.11.008","volume":"288","author":"C Geis","year":"2017","unstructured":"Geis C, et al. NOX4 is an early initiator of neuropathic pain. Exp Neurol. 2017;288:94\u2013103.","journal-title":"Exp Neurol."},{"key":"10204_CR13","doi-asserted-by":"publisher","first-page":"1388131","DOI":"10.3389\/fneur.2024.1388131","volume":"15","author":"S-C Gu","year":"2024","unstructured":"Gu S-C, et al. Association of body mass index with rapid eye movement sleep behavior disorder in Parkinson\u2019s disease. Front Neurol. 2024;15:1388131.","journal-title":"Front Neurol."},{"key":"10204_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113248","volume":"152","author":"L Guan","year":"2022","unstructured":"Guan L, et al. Dioscin alleviates Alzheimer\u2019s disease through regulating RAGE\/NOX4 mediated oxidative stress and inflammation. Biomed Pharmacother. 2022;152:113248.","journal-title":"Biomed Pharmacother."},{"issue":"3","key":"10204_CR15","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/jnc.15882","volume":"166","author":"H He","year":"2023","unstructured":"He H, et al. METTL14 is decreased and regulates m6A modification of \u03b1-synuclein in Parkinson\u2019s disease. J Neurochem. 2023;166(3):609\u201322.","journal-title":"J Neurochem."},{"issue":"9","key":"10204_CR16","doi-asserted-by":"publisher","first-page":"8368","DOI":"10.3390\/ijms24098368","volume":"24","author":"Z Huang","year":"2023","unstructured":"Huang Z, Tan Y. The potential of cylindromatosis (CYLD) as a therapeutic target in oxidative stress-associated pathologies: a comprehensive evaluation. Int J Mol Sci. 2023;24(9):8368.","journal-title":"Int J Mol Sci."},{"key":"10204_CR17","doi-asserted-by":"publisher","unstructured":"Huang Q, et al. SHANK2-AS3: a potential biomarker for Parkinson\u2019s disease and its role in neuronal apoptosis via NF-\u03baB signaling in SH-SY5Y cells. Heliyon. 2024a. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e38822.","DOI":"10.1016\/j.heliyon.2024.e38822"},{"key":"10204_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2023.578265","volume":"387","author":"R Huang","year":"2024","unstructured":"Huang R, et al. YTHDF2 alleviates microglia activation via promoting circHIPK2 degradation. J Neuroimmunol. 2024b;387:578265.","journal-title":"J Neuroimmunol."},{"issue":"6","key":"10204_CR19","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.3390\/antiox11061162","volume":"11","author":"W Kallenborn-Gerhardt","year":"2022","unstructured":"Kallenborn-Gerhardt W, Schr\u00f6der K, Schmidtko A. NADPH oxidases in pain processing. Antioxidants (Basel). 2022;11(6):1162.","journal-title":"Antioxidants (Basel)."},{"issue":"11","key":"10204_CR20","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.3390\/antiox9111056","volume":"9","author":"D Lee","year":"2020","unstructured":"Lee D, et al. Dietary antioxidants and the mitochondrial quality control: their potential roles in Parkinson\u2019s disease treatment. Antioxidants. 2020;9(11):1056.","journal-title":"Antioxidants."},{"key":"10204_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-018-1436-y","volume":"19","author":"M Li","year":"2018","unstructured":"Li M, et al. Ythdf2-mediated m6A mRNA clearance modulates neural development in mice. Genome Biol. 2018;19:1\u201316.","journal-title":"Genome Biol."},{"key":"10204_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.594387","volume":"11","author":"K Li","year":"2020","unstructured":"Li K, et al. The effect of Rotigotine extended-release microspheres alone or with Celecoxib on the inflammatory pain. Front Pharmacol. 2020;11:594387.","journal-title":"Front Pharmacol."},{"key":"10204_CR23","doi-asserted-by":"publisher","unstructured":"Li W, Deng X, Chen J. RNA-binding proteins in regulating mRNA stability and translation: roles and mechanisms in cancer. Semin Cancer Biol. 2022. https:\/\/doi.org\/10.1016\/j.semcancer.2022.03.025.","DOI":"10.1016\/j.semcancer.2022.03.025"},{"key":"10204_CR24","doi-asserted-by":"publisher","unstructured":"Li Z, et al. m6A demethylase FTO-mediated upregulation of BAP1 induces neuronal ferroptosis via the p53\/SLC7A11 axis in the MPP+\/MPTP-induced Parkinson\u2019s disease model. ACS Chem Neurosci. 2025. https:\/\/doi.org\/10.1021\/acschemneuro.4c00620.","DOI":"10.1021\/acschemneuro.4c00620"},{"issue":"6","key":"10204_CR25","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.7150\/thno.107436","volume":"15","author":"Z Liang","year":"2025","unstructured":"Liang Z, et al. Epigenetic regulation-mediated disorders in dopamine transporter endocytosis: a novel mechanism for the pathogenesis of Parkinson\u2019s disease. Theranostics. 2025;15(6):2250.","journal-title":"Theranostics."},{"issue":"7","key":"10204_CR26","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.4103\/NRR.NRR-D-23-01265","volume":"20","author":"Z Lin","year":"2025","unstructured":"Lin Z, et al. NOX4 exacerbates Parkinson\u2019s disease pathology by promoting neuronal ferroptosis and neuroinflammation. Neural Regen Res. 2025;20(7):2038\u201352.","journal-title":"Neural Regen Res."},{"issue":"6","key":"10204_CR27","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1007\/s12035-023-03270-6","volume":"60","author":"T Liu","year":"2023","unstructured":"Liu T, et al. Methyl ferulic acid alleviates neuropathic pain by inhibiting Nox4-induced ferroptosis in dorsal root ganglia neurons in rats. Mol Neurobiol. 2023;60(6):3175\u201389.","journal-title":"Mol Neurobiol."},{"key":"10204_CR28","doi-asserted-by":"publisher","first-page":"1338609","DOI":"10.3389\/fneur.2024.1338609","volume":"15","author":"G Lombardi","year":"2024","unstructured":"Lombardi G, et al. Comparing the effects of augmented virtual reality treadmill training versus conventional treadmill training in patients with stage II-III Parkinson\u2019s disease: the VIRTREAD-PD randomized controlled trial protocol. Front Neurol. 2024;15:1338609.","journal-title":"Front Neurol."},{"issue":"1","key":"10204_CR29","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13578-024-01266-w","volume":"14","author":"Y Maimaiti","year":"2024","unstructured":"Maimaiti Y, et al. NOX4-mediated astrocyte ferroptosis in Alzheimer\u2019s disease. Cell Biosci. 2024;14(1):88.","journal-title":"Cell Biosci."},{"key":"10204_CR30","doi-asserted-by":"crossref","unstructured":"Mar\u00edn-Rubio JL, et al. CYLD in health and disease. Dis Model Mech. 2023;16(6):dmm050093","DOI":"10.1242\/dmm.050093"},{"issue":"4","key":"10204_CR31","doi-asserted-by":"publisher","first-page":"284","DOI":"10.2174\/1389450115666141024152421","volume":"16","author":"JB Mathis","year":"2015","unstructured":"Mathis JB, et al. CYLD-mediated signaling and diseases. Curr Drug Targets. 2015;16(4):284\u201394.","journal-title":"Curr Drug Targets."},{"issue":"5","key":"10204_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115618","volume":"44","author":"C Miller","year":"2025","unstructured":"Miller C, et al. Pathological \u03b1-synuclein dysregulates epitranscriptomic writer METTL3 to drive neuroinflammation in microglia. Cell Rep. 2025;44(5):115618.","journal-title":"Cell Rep."},{"issue":"4","key":"10204_CR33","doi-asserted-by":"publisher","first-page":"fcae210","DOI":"10.1093\/braincomms\/fcae210","volume":"6","author":"D Nardelli","year":"2024","unstructured":"Nardelli D, et al. Pain in Parkinson\u2019s disease: a neuroanatomy-based approach. Brain Commun. 2024;6(4):fcae210.","journal-title":"Brain Commun."},{"key":"10204_CR34","doi-asserted-by":"publisher","unstructured":"Nardi L, et al. Role of CYLD in brain physiology and pathology. J Mol Med. 2025. https:\/\/doi.org\/10.1007\/s00109-025-02521-4.","DOI":"10.1007\/s00109-025-02521-4"},{"issue":"7","key":"10204_CR35","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1097\/j.pain.0000000000002218","volume":"162","author":"Z Pan","year":"2021","unstructured":"Pan Z, et al. Methyltransferase-like 3 contributes to inflammatory pain by targeting TET1 in YTHDF2-dependent manner. Pain. 2021;162(7):1960\u201376.","journal-title":"Pain."},{"issue":"13","key":"10204_CR36","doi-asserted-by":"publisher","first-page":"eabh1824","DOI":"10.1126\/sciadv.abh1824","volume":"8","author":"SK Pirooznia","year":"2022","unstructured":"Pirooznia SK, et al. Deubiquitinase CYLD acts as a negative regulator of dopamine neuron survival in Parkinson\u2019s disease. Sci Adv. 2022;8(13):eabh1824.","journal-title":"Sci Adv."},{"key":"10204_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2020.135315","volume":"737","author":"X Qiu","year":"2020","unstructured":"Qiu X, et al. Genome-wide identification of m6A-associated single-nucleotide polymorphisms in Parkinson\u2019s disease. Neurosci Lett. 2020;737:135315.","journal-title":"Neurosci Lett."},{"issue":"11","key":"10204_CR38","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.3390\/biomedicines12112417","volume":"12","author":"N Rei","year":"2024","unstructured":"Rei N, et al. Microbiota orchestra in Parkinson\u2019s disease: the nasal and oral maestros. Biomedicines. 2024;12(11):2417.","journal-title":"Biomedicines."},{"issue":"3","key":"10204_CR39","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.3390\/ijms25031618","volume":"25","author":"FJ Romero","year":"2024","unstructured":"Romero FJ, et al. Small extracellular vesicles and oxidative pathophysiological mechanisms in retinal degenerative diseases. Int J Mol Sci. 2024;25(3):1618.","journal-title":"Int J Mol Sci."},{"issue":"11","key":"10204_CR40","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1007\/s00109-024-02489-7","volume":"102","author":"E Schramm","year":"2024","unstructured":"Schramm E, et al. Constitutive expression of the deubiquitinating enzyme CYLD does not affect microglia phenotype or function in homeostasis and neuroinflammation. J Mol Med (Berl). 2024;102(11):1381\u201393.","journal-title":"J Mol Med (Berl)."},{"key":"10204_CR41","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.freeradbiomed.2016.05.016","volume":"97","author":"T Seredenina","year":"2016","unstructured":"Seredenina T, et al. Evaluation of NADPH oxidases as drug targets in a mouse model of familial amyotrophic lateral sclerosis. Free Radic Biol Med. 2016;97:95\u2013108.","journal-title":"Free Radic Biol Med."},{"issue":"10","key":"10204_CR42","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.3390\/cells10102694","volume":"10","author":"L Shu","year":"2021","unstructured":"Shu L, et al. Emerging roles of N6-methyladenosine modification in neurodevelopment and neurodegeneration. Cells. 2021;10(10):2694.","journal-title":"Cells."},{"issue":"1","key":"10204_CR43","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3233\/JPD-202457","volume":"12","author":"H Staunton","year":"2022","unstructured":"Staunton H, et al. A patient-centered conceptual model of symptoms and their impact in early Parkinson\u2019s disease: a qualitative study. J Parkinsons Dis. 2022;12(1):137\u201351.","journal-title":"J Parkinsons Dis."},{"issue":"1","key":"10204_CR44","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/cdd.2009.43","volume":"17","author":"S Sun","year":"2010","unstructured":"Sun S. CYLD: a tumor suppressor deubiquitinase regulating NF-\u03baB activation and diverse biological processes. Cell Death Differ. 2010;17(1):25\u201334.","journal-title":"Cell Death Differ."},{"key":"10204_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.873020","volume":"12","author":"C Tan","year":"2022","unstructured":"Tan C, et al. YY1-targeted RBM15B promotes hepatocellular carcinoma cell proliferation and Sorafenib resistance by promoting TRAM2 expression in an m6A-dependent manner. Front Oncol. 2022;12:873020.","journal-title":"Front Oncol."},{"key":"10204_CR46","doi-asserted-by":"publisher","unstructured":"Tang L, et al. Induction mechanism of ferroptosis, necroptosis, and pyroptosis: a novel therapeutic target in nervous system diseases. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241210127.","DOI":"10.3390\/ijms241210127"},{"key":"10204_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.prdoa.2023.100219","volume":"9","author":"R Tedeschi","year":"2023","unstructured":"Tedeschi R. Automated mechanical peripheral stimulation for gait rehabilitation in Parkinson\u2019s disease: a comprehensive review. Clin Parkinsonism Relat Disord. 2023;9:100219.","journal-title":"Clin Parkinsonism Relat Disord."},{"key":"10204_CR48","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.freeradbiomed.2021.03.021","volume":"168","author":"G Wack","year":"2021","unstructured":"Wack G, et al. Nox4-dependent upregulation of S100A4 after peripheral nerve injury modulates neuropathic pain processing. Free Radic Biol Med. 2021;168:155\u201367.","journal-title":"Free Radic Biol Med."},{"issue":"20","key":"10204_CR49","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020104514","volume":"39","author":"L Wang","year":"2020","unstructured":"Wang L, et al. m6A RNA methyltransferases METTL3\/14 regulate immune responses to anti-PD-1 therapy. EMBO J. 2020;39(20):e104514.","journal-title":"EMBO J."},{"issue":"4","key":"10204_CR50","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.molmed.2022.02.003","volume":"28","author":"Z-L Wang","year":"2022","unstructured":"Wang Z-L, et al. Ferroptosis in Parkinson\u2019s disease: glia\u2013neuron crosstalk. Trends Mol Med. 2022;28(4):258\u201369.","journal-title":"Trends Mol Med."},{"issue":"1","key":"10204_CR51","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/psyg.12900","volume":"23","author":"X Xing","year":"2023","unstructured":"Xing X, et al. Role of the OTUB1\/IRF7\/NOX4 axis in oxidative stress injury and inflammatory responses in mice with Parkinson\u2019s disease. Psychogeriatrics. 2023;23(1):32\u201344.","journal-title":"Psychogeriatrics."},{"key":"10204_CR52","doi-asserted-by":"publisher","first-page":"1522157","DOI":"10.3389\/fonc.2025.1522157","volume":"15","author":"Y Yan","year":"2025","unstructured":"Yan Y, Fu J. The human 18S rRNA m6A methyltransferase METTL5 promotes tumorigenesis via DEPDC1 in lung squamous cell carcinoma. Front Oncol. 2025;15:1522157.","journal-title":"Front Oncol."},{"issue":"1","key":"10204_CR53","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1038\/s41467-019-10669-0","volume":"10","author":"S Yang","year":"2019","unstructured":"Yang S, et al. m6A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade. Nat Commun. 2019;10(1):2782.","journal-title":"Nat Commun."},{"key":"10204_CR54","doi-asserted-by":"publisher","unstructured":"Yang L, Zhang L, Luo Z. Comparative pharmacokinetics and bioequivalence evaluation of two formulations of Pramipexole Dihydrochloride Extended-Release Tablets in healthy Chinese subjects under fasted and fed states: a randomized, open-label, single-dose, two-period crossover clinical trial. Drug Des Devel Ther. 2023. https:\/\/doi.org\/10.2147\/DDDT.S421449.","DOI":"10.2147\/DDDT.S421449"},{"issue":"1","key":"10204_CR55","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s40035-023-00392-8","volume":"12","author":"X Zhang","year":"2023","unstructured":"Zhang X, Tang B, Guo J. Parkinson\u2019s disease and gut microbiota: from clinical to mechanistic and therapeutic studies. Transl Neurodegener. 2023;12(1):59.","journal-title":"Transl Neurodegener."},{"key":"10204_CR56","doi-asserted-by":"publisher","first-page":"1180404","DOI":"10.3389\/fendo.2023.1180404","volume":"14","author":"S Zhao","year":"2023","unstructured":"Zhao S, et al. Crosstalk of disulfidptosis-related subtypes, establishment of a prognostic signature and immune infiltration characteristics in bladder cancer based on a machine learning survival framework. Front Endocrinol. 2023;14:1180404.","journal-title":"Front Endocrinol."},{"issue":"6","key":"10204_CR57","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3892\/ijmm.2025.5526","volume":"55","author":"H Zhi","year":"2025","unstructured":"Zhi H, et al. Ceftriaxone affects ferroptosis and alleviates glial cell activation in Parkinson\u2019s disease. Int J Mol Med. 2025;55(6):85.","journal-title":"Int J Mol Med."},{"issue":"4","key":"10204_CR58","first-page":"1679","volume":"28","author":"M Zhuang","year":"2023","unstructured":"Zhuang M, et al. YTHDF2 in dentate gyrus is the m6A reader mediating m6A modification in hippocampus-dependent learning and memory. Mol Psychiatry. 2023;28(4):1679\u201391.","journal-title":"Mol Psychiatry."}],"container-title":["Cell Biology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10565-026-10204-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-026-10204-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-026-10204-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T14:03:38Z","timestamp":1783519418000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10565-026-10204-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10204"],"URL":"https:\/\/doi.org\/10.1007\/s10565-026-10204-0","relation":{},"ISSN":["1573-6822"],"issn-type":[{"value":"1573-6822","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,6]]},"assertion":[{"value":"7 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The animal experiment was authorized via the Animal Ethical and Welfare Committee of Renji Hospital, School of Medicine, Shanghai Jiao Tong University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"During the preparation of this work the authors did not use any AI-assisted technology.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Generative AI and AI-assisted technologies in the writing process"}}],"article-number":"87"}}